pretickt

Medtronic Plc (MDT)

Healthcare · end-of-day data as of Oct 16, 2026

Medtronic Plc
MDT · $121B
$94.75+14.8%last 60 sessions · close Oct 16, 2026
$72.50$101.9752 weeks
Buy · 29 analystsPT $98.54 +4.0%
  • P/E vs own-3.5%
  • P/E vs sector-17.1%
  • Target upside+4.0%
  • Off 52w high-7.1%
  • Insiders-$5.89M
  • FCF yield+5.1%
  • Earnings in32d
  • Trendsideways
  • Sector▲ +16.0%
  • RSI65
  • MA20×50Death 7d ago
  • Volume0.9x
  • Support-0.8%
  • Resistance+4.6%

The average 12-month analyst price target for MDT is $98.54, 4.0% above the last close of $94.75 on Oct 16, 2026; targets range from $80.98 to $115.49. Rating consensus: Buy.

Snapshot

  • P/E23.3x
  • P/E vs sector-17.1%
  • P/E vs own-3.5%
  • Target upside+4.0%
  • ConsensusBuy
  • Market cap$121B
  • FCF yield+5.1%
  • Insiders-$5.89M
  • Earnings in32d
  • News1.00

Why it moved

Medtronic Plc (MDT) fell 0.7% on Oct 16, 2026.

The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move came from the market as a whole.

Market (SPY)-1.1%
Healthcare sector+0.4%
MDT specific0.0%

1 story on the day (30-day average 1.9).

Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.

Price and events

⇔⇕$74.42$82.96$91.51$100Oct 25Jan 26Apr 26Jul 26Oct 26EADAAEDEADAEDE

Last close $94.75 · +3.0% over 1y · E earnings · D dividend · S split · A analyst rating change

Technicals

  • Trendsideways
  • Sector▲ +16.0%
  • MAs20▲ 50▲ 100▲ 200▲
  • Above MAs4 of 4 above
  • MA20×50Death 7d ago
  • RSI65
  • Support-0.8%
  • Resistance+4.6%
  • Off 52w high-7.1%
  • Off ATH-17.3%
  • 52w range$94.75
  • Bollingerupper half
  • MACD0.91
  • ATR+2.5%
  • Volume0.9x

Analyst price targets

Low$80.98
Average$98.54
Median$96.67
High$115.49
Upside+4.0%

16 firms with a target in the last 12 months · last close $94.75 · as of Oct 16, 2026

⇔⇕$70.14$83.11$96.08$109$122Oct 25Mar 26Aug 26Jan 27Jun 27+11%+17%-2%+6%+4%
— actual price● bullish target● bearish targethover a dot to see the analysts behind it · wheel or drag to move through time · drag the price axis on the right to stretch it · double-click resets

Strong buy 3 · Buy 16 · Hold 10 · Sell 0 · Strong sell 0

Revenue and free cash flow

Q1 FY2027: Revenue +13.7% year over year, free cash flow 13.2% of revenue, operating margin 18.1%.

RevenueFree cash flow
Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027
Q1 FY2027Jul 31, 2026$9.76B1.14$1.29B65.0%18.1%15.1%
Q4 FY2026Apr 24, 2026$9.81B0.96$2.08B75.9%15.9%12.7%
Q3 FY2026Jan 23, 2026$9.02B0.89$2.3B64.9%19.7%12.7%
Q2 FY2026Oct 24, 2025$8.96B1.07$457M60.3%18.8%15.3%
Q1 FY2026Jul 25, 2025$8.58B0.81$584M57.7%16.8%12.1%
Q4 FY2025Apr 25, 2025$8.93B0.82$2.07B64.7%16.1%11.8%
Q3 FY2025Jan 24, 2025$8.29B1.01$2.1B66.5%19.9%15.6%
Q2 FY2025Oct 25, 2024$8.4B0.99$554M64.9%19.0%15.1%

Peers

20D
1ABTAbbott Laboratories$104.89+0.2%-17.7%+16.6%33.7$181B
2MDTMedtronic Plc$94.75-0.7%-7.1%+4.0%23.3$121B
3SYKStryker Corporation$294.66+0.5%-23.3%+23.9%30.5$113B
4BSXBoston Scientific Corporation$44.39+0.6%-57.7%+50.1%18.0$64.33B
5EWEdwards Lifesciences Corporation$86.60-1.7%-9.0%+15.2%49.8$49.9B
6DXCMDexCom, Inc.$86.04-1.9%-6.8%+12.7%34.0$32.47B
7GEHCGE HealthCare Technologies Inc.$69.57-1.1%-21.0%+20.2%20.2$31.42B
8ZBHZimmer Biomet Holdings, Inc.$94.98+0.6%-7.7%+9.0%23.1$18.12B

Data as of Oct 16, 2026 close.

Latest news